Survival with AIDS in New York

Peter Bacchetti; Dennis Osmond; Richard E. Chaisson; Andrew R. Moss; Gerard E. Mullin; Arthur L. Sheppell; Joseph R. Masci; Richard Rothenberg; Rand Stoneburner; John Milberg; Mary Woelfel; Benedict Truman; Robert Parker

doi:10.1056/NEJM198806023182211

Survival with AIDS in New York

Peter Bacchetti, Dennis Osmond, Richard E. Chaisson, Andrew R. Moss, Gerard E. Mullin, Arthur L. Sheppell, Joseph R. Masci, Richard Rothenberg, Rand Stoneburner, John Milberg, Mary Woelfel, Benedict Truman, Robert Parker

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Abstract

To the Editor: Rothenberg et al. report (Nov. 19 issue)¹ that the survival rates for patients with the acquired immunodeficiency syndrome (AIDS) in New York City are substantially higher than those reported in our studies of patients in San Francisco.^{2, 3} For example, the two-year survival rates in New York were 51 percent for patients initially given a diagnosis of Kaposi's sarcoma only and 25 percent for patients with Pneumocystis carinii pneumonia only; the corresponding rates in San Francisco were 34 and 2 percent (Fig. 1 and ²). The primary reason for these differences is that the rates in San Francisco are.

Original language	English (US)
Pages (from-to)	1464-1465
Number of pages	2
Journal	New England Journal of Medicine
Volume	318
Issue number	22
DOIs	https://doi.org/10.1056/NEJM198806023182211
State	Published - Jun 2 1988
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM198806023182211

Cite this

@article{3081cfc6b802423b9945dbb4de1c7b88,

title = "Survival with AIDS in New York",

abstract = "To the Editor: Rothenberg et al. report (Nov. 19 issue)1 that the survival rates for patients with the acquired immunodeficiency syndrome (AIDS) in New York City are substantially higher than those reported in our studies of patients in San Francisco.2, 3 For example, the two-year survival rates in New York were 51 percent for patients initially given a diagnosis of Kaposi's sarcoma only and 25 percent for patients with Pneumocystis carinii pneumonia only; the corresponding rates in San Francisco were 34 and 2 percent (Fig. 1 and 2). The primary reason for these differences is that the rates in San Francisco are.",

author = "Peter Bacchetti and Dennis Osmond and Chaisson, {Richard E.} and Moss, {Andrew R.} and Mullin, {Gerard E.} and Sheppell, {Arthur L.} and Masci, {Joseph R.} and Richard Rothenberg and Rand Stoneburner and John Milberg and Mary Woelfel and Benedict Truman and Robert Parker",

year = "1988",

month = jun,

day = "2",

doi = "10.1056/NEJM198806023182211",

language = "English (US)",

volume = "318",

pages = "1464--1465",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Survival with AIDS in New York

AU - Bacchetti, Peter

AU - Osmond, Dennis

AU - Chaisson, Richard E.

AU - Moss, Andrew R.

AU - Mullin, Gerard E.

AU - Sheppell, Arthur L.

AU - Masci, Joseph R.

AU - Rothenberg, Richard

AU - Stoneburner, Rand

AU - Milberg, John

AU - Woelfel, Mary

AU - Truman, Benedict

AU - Parker, Robert

PY - 1988/6/2

Y1 - 1988/6/2

N2 - To the Editor: Rothenberg et al. report (Nov. 19 issue)1 that the survival rates for patients with the acquired immunodeficiency syndrome (AIDS) in New York City are substantially higher than those reported in our studies of patients in San Francisco.2, 3 For example, the two-year survival rates in New York were 51 percent for patients initially given a diagnosis of Kaposi's sarcoma only and 25 percent for patients with Pneumocystis carinii pneumonia only; the corresponding rates in San Francisco were 34 and 2 percent (Fig. 1 and 2). The primary reason for these differences is that the rates in San Francisco are.

AB - To the Editor: Rothenberg et al. report (Nov. 19 issue)1 that the survival rates for patients with the acquired immunodeficiency syndrome (AIDS) in New York City are substantially higher than those reported in our studies of patients in San Francisco.2, 3 For example, the two-year survival rates in New York were 51 percent for patients initially given a diagnosis of Kaposi's sarcoma only and 25 percent for patients with Pneumocystis carinii pneumonia only; the corresponding rates in San Francisco were 34 and 2 percent (Fig. 1 and 2). The primary reason for these differences is that the rates in San Francisco are.

UR - http://www.scopus.com/inward/record.url?scp=0023919236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023919236&partnerID=8YFLogxK

U2 - 10.1056/NEJM198806023182211

DO - 10.1056/NEJM198806023182211

M3 - Letter

C2 - 3367954

AN - SCOPUS:0023919236

SN - 0028-4793

VL - 318

SP - 1464

EP - 1465

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -

Survival with AIDS in New York

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this